Author(s):
Almira Almurzayeva, Kairat Zhakipbekov, Ubaidilla Datkhayev, Olga Posilkina, Akdidar Egizbayeva
Email(s):
mira.almurza@gmail.com
DOI:
10.52711/0974-360X.2025.00665 
Address:
Almira Almurzayeva1*, Kairat Zhakipbekov1, Ubaidilla Datkhayev1, Olga Posilkina2, Akdidar Egizbayeva1
1Asfendiyarov Kazakh National Medical University, 050000, 94 Tole bi Str., Almaty, Republic of Kazakhstan.
2National University of Pharmacy, 61002, 53 Hryhorii Skovoroda Str., Kharkiv, Ukraine.
*Corresponding Author
Published In:
Volume - 18,
Issue - 10,
Year - 2025
ABSTRACT:
Background: In the modern pharmaceutical industry, characterised by a high degree of competition and rapid technological development, the relevance of the study of mechanisms to enhance the competitiveness of production is obvious. The purpose of this study was to analyse the financial and operational aspects of the activities of the Sultan Limited Liability Partnership (LLP) for the period from 2020 to 2023 to identify potential reserves for improving competitiveness. Materials and Methods: To achieve this goal, quantitative analysis methods were applied, including multiple linear regression using R analysis software, which allowed assessing the relationship between depreciation charges and the residual value of fixed assets, and analysing the dynamics of sales and procurement turnover and the balance of changes in financial results, cash flows of Sultan LLP for the period from 2020 to 2023. In addition to the analysis of depreciation processes, an assessment of the liquidity and profitability of Sultan LLP was carried out. Results: The analysis of liquidity and profitability ratios revealed the company’s ability to cover short-term liabilities and its effectiveness in generating profits. During the study of Sultan LLP for the period 2020-2023, it was revealed that the dynamics of turnover and changes in the balance of the company reflect key aspects of its operational efficiency and financial stability. Especially significant was the discovery that 84% of the balance variations at the end of the period can be explained through turnover, emphasising the critical role of effective working capital management. Regression analysis in R showed that debit turnover increased from KZT 2.04 billion in 2020 to KZT 2.42 billion in 2022, while credit turnover peaked at 2.55 billion in 2022, indicating significant fluctuations in operating activities. A significant increase in the balance from KZT 81.3 million in 2020 to KZT 274.4 million in 2021 indicates a potential improvement in the financial situation. Conclusion: These results highlight the importance of strategic financial management, including diversifying income sources and optimising inventory management to strengthen financial sustainability and maintain market competitiveness.
Cite this article:
Almira Almurzayeva, Kairat Zhakipbekov, Ubaidilla Datkhayev, Olga Posilkina, Akdidar Egizbayeva. Improvement of Mechanisms for Increasing the Competitiveness of Pharmaceutical Industries. Research Journal of Pharmacy and Technology. 2025;18(10):4625-4. doi: 10.52711/0974-360X.2025.00665
Cite(Electronic):
Almira Almurzayeva, Kairat Zhakipbekov, Ubaidilla Datkhayev, Olga Posilkina, Akdidar Egizbayeva. Improvement of Mechanisms for Increasing the Competitiveness of Pharmaceutical Industries. Research Journal of Pharmacy and Technology. 2025;18(10):4625-4. doi: 10.52711/0974-360X.2025.00665 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-10-4
REFERENCES:
1. Baltabay BS. Kabdylkanova EZ. Omar GT. Orazbek KO. Satmbekova DK. History of Pharmacy of Kazakhstan during the Years of Independence. Theoretical and Applied Science. 2021; 104(12): 1304-8. doi.org/10.15863/TAS.2021.12.104.145
2. Bukatov YB. Gimranova GI. Shanin SA. State Management of the Sphere of Circulation of Medicines in the Context of the COVID-19 Pandemic. Economics: The Strategy and Practice. 2021; 16(3): 227-42. doi.org/10.51176/1997-9967-2021-3-227-242
3. Frolova ED. Abdurahkmanova ZA. Ishukov AA. Participation of Kazakhstan Pharmaceutical Companies in Global Value Chains. Economy of Region. 2021; 17(2): 473-85. doi.org/10.17059/ekon.reg.2021-2-9
4. Assan A. Moldaliyev I. Kerimbayeva Z. Gaipov A. Utepova D. Magzumova RZ. Tsoy L. Issayev A. Aljofan M. A Retrospective Analysis of Pharmacotherapy in Kazakhstan: Assessment of the Rational Prescription and Use of Antibiotics in the Nephrology Department of a Multidisciplinary Hospital. Electronic Journal of General Medicine. 2022; 19(6): em422. doi.org/10.29333/ejgm/12576
5. Beisenova R. Tulegenova S. Tazitdinova R. Orkeyeva A. Beisenbekova Z. The Problem of Water Resources Pollution with Active Pharmaceutical Substances and the Possibility of Its Solving. Journal of Environmental Management and Tourism. 2022; 13(5): 1353-60. doi.org/10.14505/jemt.v13.5(61).12
6. CEIC Data. 2025. Kazakhstan Turnover Value: KASE: KZT. https://www.ceicdata.com/en/kazakhstan/kazakhstan-stock-exchange-turnover/turnover-value-kase-kzt
7. Kerimkhulle S. Obrosova N. Shananin A. Tokhmetov A. Young Duality for Variational Inequalities and Nonparametric Method of Demand Analysis in Input–Output Models with Inputs Substitution: Application for Kazakhstan Economy. Mathematics. 2023; 11(19): 4216. doi.org/10.3390/math11194216
8. Yuliia P. Al-Ababneh HA. Symonenko O. The Impact of Globalisation on Economic Systems and Social Structures. Dialogues in Humanities and Social Sciences. 2025; 3(1): 63-72. doi.org/10.71261/dhss/3.1.63.72
9. Chorna NP. Development of Agrarian Business in Ukraine under Influence of World Financial and Economic Crisis. Actual Problems of Economics. 2009; 11: 40-8. https://www.researchgate.net/publication/294367857_Development_of_Agrarian_business_in_Ukraine_under_influence_of_world_financial_and_economic_crisis
10. Tiurina A. Petrunenko I. Guliyeva S. Qazizade E. Aliyeva T. Social Responsibility and Modern Business during the Global Crisis: Threat or Opportunity for the Guam Member Countries. Journal of Eastern European and Central Asian Research. 2023; 10(2): 201-12. doi.org/10.15549/jeecar.v10i2.1276
11. Karimli I. Eyvazov E. Azizova R. Rizayeva V. Mazanova O. The Creation and Increase of Value Added in the Value Chain and Its Impact on the Price. WSEAS Transactions on Business and Economics. 2022; 19: 1967-78. doi.org/10.37394/23207.2022.19.176
12. Salah JY. Properties of the Modified Caputo's Derivative Operator for Certain Analytic Functions. International Journal of Pure and Applied Mathematics. 2016; 109(3): 665-71. doi.org/10.12732/ijpam.v109i3.14
13. Tepavicharova M. Aleksejeva L. Vazov R. Interaction of Subordinate Staff Management and Factors of Economic Performance of Companies in the Bulgarian Mining and Quarrying Sector. E3S Web of Conferences. 2020; 174: 04031. doi.org/10.1051/e3sconf/202017404031
14. Musayeva N. Atakishiyeva N. Mammadova M. Mammadova U. Innovations in the Azerbaijan Auditing Activity. Review of Economics and Finance. 2022; 20: 1286-94. doi.org/10.55365/1923.x2022.20.141
15. Kerimkhulle S. Saliyeva A. Makhazhanova U. Kerimkulov Z. Adalbek A. Taberkhan R. The Input-Output Analysis for the Wholesale and Retail Trade Industry of the Kazakhstan Statistics. E3S Web of Conferences. 2023; 376: 05023. doi.org/10.1051/e3sconf/202337605023
16. Rajagukguk J. Siagian H. The Effect of Liquidity and Total Asset Turnover on Profitability: Research Study on Pharmaceutical Companies in Indonesia Stock Exchange. Ekonomis: Journal of Economics and Business. 2021; 5(2): 444-8.
17. Ishchenko VV. Clustering of Pharmaceutical Companies by Liquidity Level. Youth Economic Bulletin of HNUE named after Semen Kuznets. 2024; 3: 144-7.
18. Rehman HU. Darus M. Salah J. Generalizing Certain Analytic Functions Correlative to the n -th Coefficient of Certain Class of Bi-Univalent Functions. Journal of Mathematics. 2021; 2021: 6621315. doi.org/10.1155/2021/6621315
19. Innola N. Roman C. Nelia C. Roman B. Viktor L. Simulation of Comprehensive Assessments of Personnel Innovation Development Management System. Lecture Notes in Networks and Systems. 2022; 486: 95-108. doi.org/10.1007/978-3-031-08087-6_7
20. Mukhtar AH. Nawang NI. Organizational Development and Corporate Law Excellence: A Perspective of Human Resource Development and Behavioral Training. Review of Law and Social Sciences. 2025; 3(1): 15-21. doi.org/10.71261/rlss/3.1.15.21
21. Tömöri G. Lakatos V. Mártha BB. The Effect of Financial Risk Taking on Profitability in the Pharmaceutical Industry. Economies. 2021; 9(4): 153. doi.org/10.3390/economies9040153
22. Pererva I. Myronova O. Use of Creative Marketing in the Implementation of Enterprise Strategy. Economics of Development. 2023; 22(2): 28-40.
23. Karimli I. Azizova R. Karimov R. Bayramov I. Al Shamsi AJ. The Reality and Prospects of Economic Development of the South Caucasus Region: New Approaches to the Influence of Internal and External Economic Factors. WSEAS Transactions on Computer Research. 2024; 12: 132-42.
24. Mariam S. Khawaja KF. Khan HGA. Ahmad F. Adaptation and Validation of Responsible Innovation Practices Scale for Innovativeness and Competitiveness of Pharmaceutical Companies in Pakistan. NUST Journal of Social Sciences and Humanities. 2023; 8(2): 185-207. doi.org/10.51732/njssh.v8i2.143
25. Tkachuk H. Burachek I. Vyhovskyi V. Sotnyk A. Buzhymska K. Food Company Competitiveness Determination using Marketing Monitoring. Ekonomika APK. 2024; 31(4): 67-77. doi.org/10.32317/ekon.apk/4.2024.67
26. Sahaidak-Nikitiuk R. Holybtsova K. Demchenko N. Nikitiuk V. Directions for Improving Adaptive Management Efficiency of Manufacturing Pharmaceutical Companies. EUREKA: Health Sciences. 2021; 5: 61-8. doi.org/10.21303/2504-5679.2021.002052
27. Shakouhi F. Tavakkoli-Moghaddam R. Baboli A. Bozorgi-Amiri A. A Competitive Pharmaceutical Supply Chain under the Marketing Mix Strategies and Product Life Cycle with a Fuzzy Stochastic Demand. Annals of Operations Research. 2023; 324: 1369-97. doi.org/10.1007/s10479-021-04073-5
28. Holybtsova K. Gurina-Rapinchuk IM. The methodological Support of Adaptive Management of Manufacturing Pharmaceutical Enterprises. News of Pharmacy. 2021; 101(1): 71-5. doi.org/10.24959/nphj.21.50
29. Wu D. Wang S. Chang S. Lian G. Chen Y. Comparison of External R&D and Internal R&D: Based on the Perspective of S&T Development of China’s Pharmaceutical Manufacturing Industry. PLoS ONE. 2022; 17(6): e0270271. doi.org/10.1371/journal.pone.0270271
30. Arden NS. Fisher AC. Tyner K. Yu LX. Lee SL. Kopcha M. Industry 4.0 for Pharmaceutical Manufacturing: Preparing for the Smart Factories of the Future. International Journal of Pharmaceutics. 2021; 602: 120554. doi.org/10.1016/j.ijpharm.2021.120554
31. Musayeva N. Atakishiyeva N. Mammadova U. Intangible Assets of an Enterprise: Peculiarities of Auditing and Display in Accounting. Scientific Herald of Uzhhorod University. Series Physics. 2024; 55: 2847-54. doi.org/10.54919/physics/55.2024.284ep7
32. Al-Hawary T. Amourah A. Salah J. Yousef F. Two Inclusive Subfamilies of Bi-Univalent Functions. International Journal of Neutrosophic Science. 2024; 24(4): 315-23. doi.org/10.54216/IJNS.240422
33. Kanchana L. Jayathilaka R. Factors Impacting Employee Turnover Intentions among Professionals in Sri Lankan Startups. PLoS ONE. 2023; 18(2): e0281729. doi.org/10.1371/journal.pone.0281729
34. Jumawan. Prevention Turn over Strategy: Analysis Recruitment, Career Development, Work Environment, Capability Information Technology, and Reward System. East Asian Journal of Multidisciplinary Research. 2023; 2(1): 345-56. doi.org/10.55927/eajmr.v2i1.2884
35. Barrett CB. Reardon T. Webb P. Nonfarm Income Diversification and Household Livelihood Strategies in Rural Africa: Concepts, Dynamics and Policy Implications. Food Policy. 2001; 26(4): 315-31. doi.org/10.1016/S0306-9192(01)00014-8
36. Chen CN. Lai CH. Lu GW. Huang CC. Wu LJ. Lin HC. Chen PS. Applying Simulation Optimization to Minimize Drug Inventory Costs: A Study of a Case Outpatient Pharmacy. Healthcare. 2022; 10(3): 556. doi.org/10.3390/healthcare10030556
37. OECD. Pharmaceutical research and development. In: Health at a Glance 2021: OECD Indicators. Paris, OECD Publishing. 2021: 244-5. doi.org/10.1787/6e38c622-en
38. Guan X. Chen L. Xia Q. Qin Z. Innovation Efficiency of Chinese Pharmaceutical Manufacturing Industry from the Perspective of Innovation Ecosystem. Sustainability. 2022; 14(20): 12993. doi.org/10.3390/su142012993
39. Sarkis M. Bernardi A. Shah N. Papathanasiou MM. Emerging Challenges and Opportunities in Pharmaceutical Manufacturing and Distribution. Processes. 2021; 9(3): 457. doi.org/10.3390/PR9030457
40. Gechbaia B. Goletiani K. Shoshiashvili S. Kacharava K. Lochoshvili K. The Role of Global Economic Change in the Transformation of Georgian Management. Scientific Bulletin of Mukachevo State University. Series “Economics”. 2024; 11(3): 47-58. doi.org/10.52566/msu-econ3.2024.47